Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 27;16(6):642.
doi: 10.3390/genes16060642.

Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle

Affiliations
Review

Collagen Type IV Variants and Kidney Cysts: Decoding the COL4A Puzzle

Matteo Rigato et al. Genes (Basel). .

Abstract

Pathogenic variants in type IV collagen genes (COL4A3, COL4A4, COL4A5) are classically associated with Alport syndrome (AS), a hereditary nephropathy primarily affecting the glomerular basement membrane (GBM). Recent findings, however, suggest a broader phenotypic spectrum that includes renal cyst formation, raising questions about overlapping mechanisms with other cystic kidney diseases. Clinically, renal cysts have been increasingly reported in patients with autosomal dominant and X-linked forms of Alport syndrome, particularly in association with glycine missense variants. The most recent studies focusing on the cystic phenotype in Alport syndrome provide growing support for the idea that variants in type IV collagen genes are associated with an increased likelihood of developing renal cysts, likely through mechanisms involving the structural integrity of renal basement membranes. In this review, we explore evidence from murine models and human studies indicating defects in collagen IV and discuss their contribution to cystogenesis. These observations underscore the need for broader genetic screening strategies and further investigation into the molecular mechanisms underlying this emerging phenotype.

Keywords: ADPKD; Alport syndrome; COL4A; collagen variants; cystic kidney disease; kidney cysts.

PubMed Disclaimer

Conflict of interest statement

In the past 3 years, C.R. has been on advisory boards or speakers’ bureaus for AstraZeneca, Afer-etica, Asahi, Bayer, B. Braun, Baxter, BioMérieux, CytoSorbents, Estor, GE, Jafron, Medica, Med-tronic, Nipro, and Toray. All the other authors declare no conflicts of interest.

Similar articles

References

    1. Wu Q., Ju C., Deng M., Liu X., Jin Z. Prevalence, Risk Factors and Clinical Characteristics of Renal Dysfunction in Chinese Outpatients with Growth Simple Renal Cysts. Int. Urol. Nephrol. 2022;54:1733–1740. doi: 10.1007/s11255-021-03065-5. - DOI - PMC - PubMed
    1. Wentland A.L., Nystrom J., Lubner M.G., Mao L., Abel E.J., Pickhardt P.J. Natural History of Simple Renal Cysts: Longitudinal CT-Based Evaluation. Abdom. Radiol. 2022;47:1124–1132. doi: 10.1007/s00261-022-03421-8. - DOI - PubMed
    1. Park H., Kim C.-S. Natural 10-Year History of Simple Renal Cysts. Korean J. Urol. 2015;56:351–356. doi: 10.4111/kju.2015.56.5.351. - DOI - PMC - PubMed
    1. Devuyst O., Ahn C., Barten T.R., Brosnahan G., Cadnapaphornchai M.A., Chapman A.B., Cornec-Le Gall E., Drenth J.P., Gansevoort R.T., Harris P.C., et al. KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) Kidney Int. 2025;107:S1–S239. doi: 10.1016/j.kint.2024.07.009. - DOI - PubMed
    1. Schmidt-Ott K.M. Mechanisms of Cyst Expansion in Polycystic Kidney Disease. J. Am. Soc. Nephrol. 2025;36:533–535. doi: 10.1681/ASN.0000000643. - DOI - PMC - PubMed

LinkOut - more resources